Related Experiment Video
Updated: Aug 17, 2026
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Morphine side effects in beta-arrestin 2 knockout mice
Kirsten M Raehal1, Julia K L Walker, Laura M Bohn
1Department of Pharmacology and Psychiatry, Ohio State University College of Medicine, Columbus, 43210-1239, USA.
Abstract:
Morphine is a potent analgesic, yet, like most opioid narcotics, it exerts unwanted side effects such as constipation and respiratory suppression, thereby limiting its clinical utility. Pharmacological approaches taken to preserve the analgesic properties, while eliminating the unwanted side effects, have met with very limited success. Here, we provide evidence that altering mu opioid receptor regulation may provide a novel approach to discriminate morphine's beneficial and deleterious effects in vivo. We have previously reported that mice lacking the G protein-coupled receptor regulatory protein, beta-arrestin 2, display profoundly altered morphine responses. beta-Arrestin 2 knockout mice have enhanced and prolonged morphine analgesia with very little morphine tolerance. In this report, we examine whether the side effects of morphine treatment are also augmented in this animal model. Surprisingly, the genetic disruption of opioid receptor regulation, while enhancing and prolonging analgesia, dramatically attenuates the respiratory suppression and acute constipation caused by morphine.
Insights
Altering beta-arrestin 2 regulation in mice enhances morphine analgesia while significantly reducing respiratory depression and constipation. This suggests a novel therapeutic target for opioid medications.
Area of Science:
- Pharmacology
- Neuroscience
- Genetics
Background:
- Morphine is a powerful pain reliever but causes side effects like constipation and respiratory suppression, limiting its use.
- Previous attempts to separate morphine's benefits from its harms via pharmacology have largely failed.
- Opioid receptor regulation is complex and involves interactions with proteins like beta-arrestin 2.
Purpose of the Study:
- To investigate if altering mu opioid receptor regulation can differentiate morphine's beneficial and harmful effects.
- To examine the impact of beta-arrestin 2 deficiency on morphine-induced side effects in a mouse model.
Main Methods:
- Utilized beta-arrestin 2 knockout mice, previously shown to have altered morphine responses.
- Assessed analgesia, tolerance, respiratory suppression, and constipation in these genetically modified mice following morphine administration.
Main Results:
- Beta-arrestin 2 knockout mice exhibited enhanced and prolonged morphine analgesia.
- These mice developed minimal morphine tolerance.
- Surprisingly, respiratory suppression and acute constipation induced by morphine were significantly attenuated in knockout mice.
Conclusions:
- Genetic disruption of beta-arrestin 2-mediated opioid receptor regulation can separate morphine's analgesic effects from its major side effects.
- Targeting beta-arrestin 2 pathways represents a novel strategy to develop safer and more effective opioid analgesics.
- This finding opens new avenues for managing pain without compromising respiratory function or causing severe constipation.
